Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
abemaciclib for treatment of metastatic breast cancer
.
Show all posts
Showing posts with label
abemaciclib for treatment of metastatic breast cancer
.
Show all posts
Wednesday, October 28, 2015
FDA grants Breakthrough Therapy Designation to Lilly's abemaciclib for treatment of metastatic breast cancer
›
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Des...
›
Home
View web version
